INTRODUCTION
Bilirubin circulates bound to albumin at one high-affinity site and two or more lower affinity sites (1, 2) . Bilirubin is rapidly removed from the circulation and enters the hepatocyte, where it is conjugated with glucuronic acid and excreted into bile (3, 4) . Albumin does not enter the hepatocyte but remains in the circulation (5) (6) (7) (8) (9) . Previous studies suggested that the unbound, rather than the bound, fraction of circulating bilirubin determines its uptake (10) (11) (12) (13) ; the proposed role of albumin-binding is to solubilize the relatively hydrophobic bilirubin molecule, and thereby prevent nonspecific passage into other tissues, particularly the brain. A more specific role for albumin binding has recently been postulated in taurocholate and oleate uptake by the liver. Luxon and Forker suggested that release of taurocholate from albumin at the hepatocyte surface occurs at a faster rate than in the systemic circulation (14) ; a cell surface-mediated conformational change in albumin was postulated which accelerates dissociation of the albumin-taurocholate complex. In other studies, Weisiger et al. suggested that uptake of albumin-bound compounds is mediated by a receptor for albumin on the liver cell surface (15, 16) .
Although these studies present the intriguing idea that hepatic uptake of bilirubin is mediated by a liver cell surface receptor for albumin, they are indirect and depend on critical assumptions, both implicit and explicit, concerning ligand-albumin interaction that include binding affinity, number of binding sites, and dissociation rate constants. The present study was designed to determine directly whether albumin facilitates the hepatic uptake of bilirubin and whether uptake of bilirubin depends on binding to albumin. In these studies, rat liver was perfused with a proteinfree fluorocarbon medium, and uptake of [3H]Bilirubin (sp act, 100 or 33 mCi/mmol) was prepared from dog bile after intravenous administration of delta [3H]-aminolevulinic acid (18) (Schwarz/Mann Div., Beckon Dickinson Immunodiagnostics, Orangeburg, NY; 60.2 Ci/mmol). Ligandin was purified to homogeneity as previously de- scribed (19) and iodinated with Na 1251 by a chloramine T method followed by Sephadex G-25 chromatography (20 To ascertain that bilirubin remained bound to albumin in the presence of fluorocarbon, circular dichroism was performed using a Cary model 60 spectropolarimeter (Varian Associates, Instrument Division, Palo Alto, CA) with a 6,000 CD attachment (1) . The temperature of the cell compartment was 25°C and a cell of 1-mm path length was used.
The ellipticity pattern of a solution of 140 MM bovine albumin and 70 MM bilirubin in Krebs-Henseleit buffer was determined at wavelengths between 350 and 550 nm. Onehalf of the volume contained in the cuvette was removed and an equal volume of 10% fluorocarbon solution was added and mixed. The ellipticity pattern was again determined.
Analysis of indicator dilution curves. Data were analyzed by the flow-limited diffusion model of Goresky (6, (21) (22) (23) . This is defined by the equation:
Cb,I,(t) = eltkc'ef(t) + e-(k2+ks)t X I e (ki-k2-k)rC f(t') Xz (k1k2t')(t t') dt'. DISCUSSION Bilirubin uptake by the liver is a rapid process of high specificity that has kinetic characteristics which suggest carrier-mediation (3, 5) . The nature of the carrier is unknown, although several candidates have been identified and purified from rat liver cell plasma membrane preparations (24) (25) (26) .
In the circulation, bilirubin is readily bound to albumin, from which it is extracted by the liver (5-7, 22, 23) . Several studies with bilirubin and bromosulphthalein (BSP)l suggested that it is the small, unbound fraction which interacts with hepatocytes, re- sulting in its removal from the circulation. Brauer and Pessotti (27) determined that, with increased concentration of BSA, BSP uptake by rat liver slices is reduced. In hypoalbuminemic patients (13), there is a reciprocal relationship between plasma albumin concentrations and hepatic BSP uptake. Similarly, in isolated perfused rat liver, influx of dibromosulphthalein is enhanced when albumin concentrations are reduced (28) . Using an ultracentrifugation method to estimate free bilirubin, Barnhart and Clarenburg suggested that a single clearance constant for free bilirubin was sufficient to describe hepatic bilirubin uptake and found that constant to be independent of the circulating albumin level (10, 11) . This concept has recently been challenged. Luxon liver perfused with buffer containing 0.5 or 5% BSA (14) . They determined free ligand by equilibrium dialysis of perfusate. Increasing albumin from 0.5 to 5.0% was sufficient to reduce the concentration of free taurocholate fivefold, but this also resulted in only a twofold reduction in hepatic uptake. On the basis of these studies, they postulated that albumin interacts with the hepatocyte surface and accelerates the release of taurocholate, which facilitates its subsequent uptake. In other studies, Weisiger et al. investigated the influence of BSA on transport by the isolated rat liver perfused with fluorocarbon after perfusion with albumin-containing buffer (16) . At a fixed albumin concentration, oleate uptake does not saturate, whereas uptake of a 1:1 molar complex of oleate and albumin is saturable, despite a nearly constant concentration of free oleate. They postulated a liver cell surface receptor for albumin which "catalyzes" the uptake of albumin-bound oleate. Similar conclusions were reached in studies of hepatic uptake of bilirubin and BSP (15 (17) .
The data in the present study revealed that albuminbinding was not necessary for the rapid uptake, metabolism, and biliary excretion of bilirubin by the liver. There was no facilitation of bilirubin uptake by albumin-binding over a 200-fold concentration range. An alternative hypothesis proposed by Weisiger et al. (16) is the presence of high-affinity, low-capacity and low-affinity, high-capacity bilirubin binding sites on the liver cell surface. Our data also suggested that the hepatic bilirubin uptake mechanism is one of high affinity for this ligand, and that it has the ability to extract it nonspecifically from circulating carriers such as albumin, ligandin, or fluorocarbon.
